Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
571.56
4.34 (0.77%)
At close: Sep 05, 2025, 3:08 PM
Regeneron Pharmaceuticals Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for REGN stock have an median target of 790.5, with a low estimate of 547 and a high estimate of 1065. The median target predicts an increase of 38.31% from the current stock price of 571.56.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 547 | 762.2 | 790.5 | 1065 |
| Change | -4.30% | 33.35% | 38.31% | 86.33% |
Latest Analyst Insight Report
RBC Capital maintains a Sector Perform rating on R... Unlock content with Pro Subscription
Updated Aug 04, 2025
| Rating | Mar 25 | Apr 25 | May 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 0 | 0 | 2 |
| Buy | 1 | 12 | 3 | 4 | 2 | 4 |
| Hold | 0 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 16 | 5 | 5 | 3 | 7 |
Financial Forecast this Year
Revenue This Year
13.88B
from 14.2B
Increased by -2.3%
Revenue Next Year
14.5B
from 13.88B
Increased by 4.5%
EPS This Year
39.38
from 40.9
Increased by -3.7%
EPS Next Year
40.25
from 39.38
Increased by 2.2%